跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 594 条关于
“MurA”
全部
594
临床试验
367
药物
26
机构
20
资讯
181
去年
Mural Oncology Gears Up for Key Data Readouts of Nemvaleukin in Ovarian Cancer and Melanoma in 2025
去年
Xoma Royalty Acquires Mural Oncology for $35.2-38.8M in Latest Biotech Liquidation Deal
去年
Mural Oncology Highlights Nemvaleukin Progress and IL-18 Program at Investor Day
去年
Mural Oncology's Nemvaleukin Trials Progressing, Data Readouts Anticipated in 2025
10个月前
FDA Approves Fosfomycin Injection for Complicated Urinary Tract Infections
去年
XOMA Royalty Acquires Mural Oncology for $36.2 Million in Strategic Biotech Consolidation
去年
Hazer and KBR Form Strategic Alliance to Commercialize Low-Emission Hydrogen Technology
去年
Mural Oncology Cuts 90% of Workforce Following Failed Cancer Immunotherapy Trials
去年
ICON Partners with Mural Health to Enhance Clinical Trial Patient Experience
9个月前
XOMA Royalty Completes $2.035 Per Share Acquisition of Mural Oncology
第 1 页,共 19 页
上一页
下一页